Go Back to Match Results for ""

Multiple Phase 1 Safety Cohorts of Nivolumab Monotherapy or Nivolumab Combination Regimens Across Relapsed/Refractory Hematologic Malignancies
Study Overview
The purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of an investigational drug called nivolumab (also known as BMS-936558).
Study Description
The purpose of this study is to test the effectiveness, safety, and tolerability of an investigational drug called nivolumab.
Additional Information
- IRB Number: 1702438409 (CA209039)
- Research Study Identifier: TX7675
- Principal Investigator: Attaya Suvannasankha, MD
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required